{"id":501,"date":"2018-10-10T22:20:30","date_gmt":"2018-10-10T21:20:30","guid":{"rendered":"http:\/\/www.trendsandtargets.com\/?p=501"},"modified":"2018-10-11T13:58:19","modified_gmt":"2018-10-11T12:58:19","slug":"trends-and-targets-for-11-10-18","status":"publish","type":"post","link":"http:\/\/www.trendsandtargets.com\/index.php\/2018\/10\/10\/trends-and-targets-for-11-10-18\/","title":{"rendered":"Trends and Targets for 11-10-18"},"content":{"rendered":"

#VERSARIEN #CAC40 #Nasdaq\u00a0 <\/b><\/span> We’ve been short staffed this week, a “man down” situation thanks to unexpected chemotherapy. This evening, while reviewing the bloodbath which occurred on the market during Wednesday, the person who usually writes this headline piece phoned to discuss a real bloodbath.<\/span><\/p>\n

It seems falling asleep with an IV Drip attached can be hilarious, if you wake up with a violent start. In the space of a few seconds, he turned his hospital room into something similar to a special effects crime scene, waving a tube squirting blood from his hand around. In the final analysis, nurses advise very little blood was lost and it just looked very, very, bad. Hopefully this proves similar behaviour to Versarien’s on 10th October, along with the wider markets.<\/span><\/p>\n

 <\/p>\n

The visuals against VRS do provide a little problem. Near term weakness below just 140p logically introduces 137p as a point at which we would hope for a bounce. The big problem comes if 137p breaks, thanks to 107p calculating as “bottom” on the immediate movement cycle.<\/span><\/p>\n

At this level, the price meets the uptrend since 2017 and there are compelling arguments favouring a bounce, if 107p makes an appearance. To be honest, we do suspect this shall prove the intention.<\/span><\/p>\n

How can it get out of trouble?<\/span><\/p>\n

 <\/p>\n

Any bounce requires exceed 176p to give some hope for the future. A move such as this anticipates 196p, essentially matching prior highs. If bettered, even slightly, the shares track record of outperformance calculates with 218p.<\/span><\/p>\n

For now, we fear this shall not becomes interesting until 107p rears its bottom.<\/span><\/p>\n

\"Chart<\/span><\/p>\n

<\/a>FUTURES<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\n\n

Time Issued<\/span><\/p>\n<\/td>\n

\n

Market<\/span><\/p>\n<\/td>\n

\n

Price At Issue<\/span><\/p>\n<\/td>\n

\n

Short Entry<\/span><\/p>\n<\/td>\n

\n

Fast Exit<\/span><\/p>\n<\/td>\n

\n

Slow Exit<\/span><\/p>\n<\/td>\n

\n

Stop<\/span><\/p>\n<\/td>\n

\n

Long Entry<\/span><\/p>\n<\/td>\n

\n

Fast Exit<\/span><\/p>\n<\/td>\n

\n

Slow Exit<\/span><\/p>\n<\/td>\n

\n

Stop<\/span><\/p>\n<\/td>\n

\n

Prior<\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

9:33:35PM<\/span><\/p>\n<\/td>\n

\n

BRENT<\/span><\/p>\n<\/td>\n

\n

82.38<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

9:37:20PM<\/span><\/p>\n<\/td>\n

\n

GOLD<\/span><\/p>\n<\/td>\n

\n

1194.2<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

‘cess<\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

9:41:03PM<\/span><\/p>\n<\/td>\n

\n

FTSE<\/span><\/p>\n<\/td>\n

\n

7054<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

9:45:33PM<\/span><\/p>\n<\/td>\n

\n

FRANCE<\/span><\/p>\n<\/td>\n

\n

5171.7<\/span><\/p>\n<\/td>\n

\n

5155<\/span><\/p>\n<\/td>\n

\n

5113<\/span><\/p>\n<\/td>\n

\n

5088<\/span><\/p>\n<\/td>\n

\n

5226<\/span><\/p>\n<\/td>\n

\n

5226<\/span><\/p>\n<\/td>\n

\n

5295<\/span><\/p>\n<\/td>\n

\n

5321<\/span><\/p>\n<\/td>\n

\n

5195<\/span><\/p>\n<\/td>\n

\n

‘cess<\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

9:49:29PM<\/span><\/p>\n<\/td>\n

\n

GERMANY<\/span><\/p>\n<\/td>\n

\n

11604<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

9:54:45PM<\/span><\/p>\n<\/td>\n

\n

US500<\/span><\/p>\n<\/td>\n

\n

2773.8<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

10:00:51PM<\/span><\/p>\n<\/td>\n

\n

DOW<\/span><\/p>\n<\/td>\n

\n

25433<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

10:11:51PM<\/span><\/p>\n<\/td>\n

\n

NASDAQ<\/span><\/p>\n<\/td>\n

\n

6983<\/span><\/p>\n<\/td>\n

\n

6976<\/span><\/p>\n<\/td>\n

\n

6967<\/span><\/p>\n<\/td>\n

\n

6909<\/span><\/p>\n<\/td>\n

\n

7002<\/span><\/p>\n<\/td>\n

\n

7242<\/span><\/p>\n<\/td>\n

\n

7439.75<\/span><\/p>\n<\/td>\n

\n

7506<\/span><\/p>\n<\/td>\n

\n

7174<\/span><\/p>\n<\/td>\n

\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

#VERSARIEN #CAC40 #Nasdaq\u00a0 We’ve been short staffed this week, a “man down” situation thanks to unexpected chemotherapy. This evening, while reviewing the bloodbath which occurred on the market during Wednesday, the person who usually writes this headline piece phoned to discuss a real bloodbath. It seems falling asleep with an IV Drip attached can be … <\/p>\n

Continue reading “Trends and Targets for 11-10-18”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-501","post","type-post","status-publish","format-standard","hentry","category-trendsandtargets"],"_links":{"self":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/comments?post=501"}],"version-history":[{"count":1,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/501\/revisions"}],"predecessor-version":[{"id":503,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/501\/revisions\/503"}],"wp:attachment":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/media?parent=501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/categories?post=501"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/tags?post=501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}